Image Alt

januar 2021

januar (Page 4)

Br J Nutr. 1999 Jul;82(1):23-30. Jackson KG, Taylor GR, Clohessy AM, Williams CM Abstract The present study was carried out to examine the effect of the dailyintake of 10 g inulin on fasting blood lipid, glucose and insulin levels in healthy middle-agedmen and women with moderately raised total plasma cholesterol (TC) and triacylglycerol (TAG) levels. This study was a double-blind randomized

Gut. 2013 Aug;62(8):1112-21. Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PG, Neyrinck AM, Bindels LB, de Vos WM, Gibson GR, Thissen JP, Delzenne NM. Abstract OBJECTIVE: To highlight the contribution of the gut microbiota to the modulation of host metabolism by dietary inulin-typefructans (ITF prebiotics)

Complement Ther Med.2016 Feb;24:96-102. Dehghan P, Farhangi MA, Tavakoli F, Aliasgarzadeh A, Akbari AM.   Abstract   BACKGROUNDS AND AIMS: Type 2 diabetic mellitus (T2DM) asone of the main causes of morbidity and mortality is associated with immune system disturbances and metabolic abnormalities. In the current study

Appl Physiol Nutr Metab. 2010 Feb;35(1):9-16. Tarini J, Wolever TM.   Abstract It is thought that diets high in dietary fibre are associated with reduced risk for type 2 diabetes, at least in part because the short-chainfattyacids (SCFAs) produced during the colonic fermentation of fibre beneficially influence circulating concentrations of free-fattyacids (FFAs) and

Eur J Clin Nutr. 2011 December ; 65(12): 1279–1286. Fernandes J, Vogt J, Wolever TMS.   Abstract Background/Objectives Colonic fermentation of dietary fibre produces short-chain fattyacids (SCFA) acetate, propionate and butyrate, which may protect against type 2 diabetes by reducing serum free-fatty acids (FFA). Since hyperinsulinemia is

Nutrition. 2014 Apr;30(4):418-23. Dehghan P, Pourghassem Gargari B, Asghari Jafar-abadi M.   Abstract Objectives Anti-inflammatory therapeutic approaches are considered for the management of type2diabetes and for the prevention of its complications. There is limited evidence regarding the effects of prebiotics on inflammation, especially in patients with type2diabetes. This trial aims